A drug with the SMILES c1ccc2c(c1)OCC(c1csc3ncnc(N4CCCC4)c13)O2 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -36.703%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
c1ccc2c(c1)OCC(c1csc3ncnc(N4CCCC4)c13)O2
c1ccc2c(c1)OCC(c1csc3ncnc(N4CCCC4)c13)O2
5-(2,3-dihydro-1,4-benzodioxin-3-yl)-4-pyrrolidin-1-ylthieno[2,3-d]pyrimidine